News

News

Ecoinomy Launches on Bitforex

We are delighted to announce the initial exchange offering of Ecoinomy (ECM) coming soon. The details are listed below – Happy trading! Subscription time:   2022/05/25 16:00 (GMT+8) – 2022/06/24 16:00 (GMT+8) Trading Time:  ECM deposit will open on 2022/10/08 at

Read More ยป

Jessica and Simon Edwards are tackling the stigma around #cannabis and its use in #paediatriccancer. In this article, they have shared their heartbreaking story about the loss of their dear son James to #DIPG.

Read the eye-opening article here ๐Ÿ‘‡
https://cannabishealthnews.co.uk/2022/11/21/cannabis-and-paediatric-cancer-it-gave-us-hope-that-we-could-save-our-son/

#Hospitals and #pharmaceutical companies around the world are increasingly being targeted by #cyberattacks due to the amount of sensitive data they handle and store.
https://www.htworld.co.uk/news/are-some-nhs-patient-records-gone-forever/

A #medicalresearch team has found that #blockchains were helpful for sharing the parameters of AI models that are often used to detect cancer.

Read the full story here ๐Ÿ‘‡
https://cryptobriefing.com/ethereum-can-be-used-for-cancer-research-heres-how-it-works/

The UKโ€™s first cannabis patient conference took place last week, with many issues and observations raised about the landscape of the #medicalcannabis market in the UK. Read the full overview from @CannabisHnews ๐Ÿ‘‡
https://lnkd.in/dsTZ5SeH

Strict licensing rules and a lack of public funding are holding back the emerging field of #psychedelic medicine in the UK, leading scientists have warned after the release of groundbreaking results on the use of #psilocybin to treat #depression ๐Ÿ‘‡

https://www.theguardian.com/science/2022/nov/08/psilocybin-research-kept-in-limbo-by-rules-and-attitudes-say-scientists

Load More...
EARN BY ENHANCING HEALTHCARE

The Ecoinomy healthcare blockchain ecosystem offers a suite of products and services for prescription organic medicine patients with the goal of powering research and healthcare innovation. 

Patients will be able to allow companies and regulators to access to their medical data to improve clinical research whilst earning rewards in ECM for their participation.